Literature DB >> 23361117

Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils.

Boris Guiu1, Pierre Bize, Daniel Gunthern, Nicolas Demartines, Nermin Halkic, Alban Denys.   

Abstract

BACKGROUND: There is currently no consensus in the literature on which embolic agent induces the greatest degree of liver hypertrophy after portal vein embolization (PVE). Only experimental results in a pig model have demonstrated an advantage of n-butyl-cyanoacrylate (NBCA) over 3 other embolic materials (hydrophilic gel, small and large polyvinyl alcohol particles) for PVE. Therefore, the aim of this human study was to retrospectively compare the results of PVE using NBCA with those using spherical microparticles plus coils.
METHODS: A total of 34 patients underwent PVE using either NBCA (n = 20), or spherical microparticles plus coils (n = 14). PVE was decided according to preoperative volumetry on the basis of contrast-enhanced CT. Groups were compared for age, sex, volume of the left lobe before PVE and future remnant liver ratio (FRL) (volume of the left lobe/total liver volume - tumor volume). The primary end point was the increase in left lobe volume 1 month after PVE. Secondary end points were procedure complications and biological tolerance.
RESULTS: Both groups were similar in terms of age, sex ratio, left lobe volume, and FRL before PVE. NBCA induced a greater increase in volume after PVE than did microparticles plus coils (respectively, +74 ± 69 % and +23 ± 14 %, p < 0.05). The amount of contrast medium used for the procedure was significantly larger when microparticles and coils rather than NBCA were used (respectively, 264 ± 43 ml and 162 ± 34 ml, p < 0.01). The rate of PVE complications as well as the biological tolerance was similar in both groups.
CONCLUSION: NBCA seems more effective than spherical microparticles plus coils to induce left-lobe hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23361117     DOI: 10.1007/s00270-013-0565-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  17 in total

1.  Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases.

Authors:  Lidewij Spelt; Ernesto Sparrelid; Bengt Isaksson; Roland G Andersson; Christian Sturesson
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 2.  Controversies of preoperative portal vein embolization.

Authors:  Benjamin J May; David C Madoff
Journal:  Hepat Oncol       Date:  2016-03-29

3.  Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization-the effect of collaterals on embolized liver volume.

Authors:  Martin Zeile; Artur Bakal; Jan E Volkmer; Gregor A Stavrou; Philip Dautel; Jan Hoeltje; Axel Stang; Karl J Oldhafer; Roland Brüning
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

4.  Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique.

Authors:  Boris Guiu; Patrick Chevallier; Alban Denys; Elisabeth Delhom; Marie-Ange Pierredon-Foulongne; Philippe Rouanet; Jean-Michel Fabre; François Quenet; Astrid Herrero; Fabrizio Panaro; Guillaume Baudin; Jeanne Ramos
Journal:  Eur Radiol       Date:  2016-04-18       Impact factor: 5.315

5.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.

Authors:  Boris Guiu; François Quenet; Laure Escal; Frédéric Bibeau; Lauranne Piron; Philippe Rouanet; Jean-Michel Fabre; Eric Jacquet; Alban Denys; Pierre-Olivier Kotzki; Daniel Verzilli; Emmanuel Deshayes
Journal:  Eur Radiol       Date:  2017-01-18       Impact factor: 5.315

6.  Ethylene vinyl alcohol copolymer for occlusion of specific portal branches during preoperative portal vein embolisation with n-butyl-cyanoacrylate.

Authors:  Romain Breguet; Sana Boudabbous; Lawrence F Pupulim; Christoph D Becker; Laura Rubbia-Brandt; Christian Toso; Maxime Ronot; Sylvain Terraz
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

Review 7.  Imaging-guided interventions modulating portal venous flow: Evidence and controversies.

Authors:  Roberto Cannella; Lambros Tselikas; Fréderic Douane; François Cauchy; Pierre-Emmanuel Rautou; Rafael Duran; Maxime Ronot
Journal:  JHEP Rep       Date:  2022-04-04

8.  Portal vein embolization with ethylene-vinyl alcohol copolymer for contralateral lobe hypertrophy before liver resection: safety, feasibility and initial experience.

Authors:  Sébastien Gautier; Olivier Chevallier; Charles Mastier; Philippe d'Athis; Nicolas Falvo; Frank Pilleul; Marco Midulla; Patrick Rat; Olivier Facy; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2021-02

9.  Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions.

Authors:  David Li; David C Madoff
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

10.  Efficacy of percutaneous transhepatic portal vein embolization using gelatin sponge particles and metal coils.

Authors:  Tomohiro Komada; Kojiro Suzuki; Takashi Mizuno; Tomoki Ebata; Masaya Matsushima; Shinji Naganawa; Masato Nagino
Journal:  Acta Radiol Open       Date:  2018-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.